Silo Pharma (SILO) Cash & Equivalents (2010 - 2026)
Silo Pharma (SILO) reported Cash & Equivalents of $3.28 million for Q2 2026, down 24.4% from $4.33 million a year earlier and down 16.0% from the prior quarter.
Powered by 
Analysis
Silo Pharma (SILO) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Silo Pharma posted Cash & Equivalents of $4.75 million, up 21.6% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of 33.3% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $3.91 million in FY2024 (+10.8%), $3.52 million in FY2023 (-69.0%), $11.37 million in FY2022 (+15.6%) and $9.84 million in FY2021 (+771.8%).
- The Q2 2026 figure ranks as the lowest quarterly Cash & Equivalents since Q1 2025.
- Year over year, Cash & Equivalents gained in four of the last seven quarters, with growth averaging 3.8%.
- The high point for year-over-year Cash & Equivalents in five years was Q4 2021 (growth of 771.8%); the low point was Q3 2023 (a decline of 98.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.9 million (Q1 2026), $4.75 million (Q4 2025) and $3.92 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Silo Pharma | 1.69 Mn | 1.69 Mn | - | 3.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.28 Mn |
| Mar 31, 2026 | 3.90 Mn |
| Dec 31, 2025 | 4.75 Mn |
| Sep 30, 2025 | 3.92 Mn |
| Jun 30, 2025 | 4.33 Mn |
| Mar 31, 2025 | 3.14 Mn |
| Dec 31, 2024 | 3.91 Mn |
| Sep 30, 2024 | 4.86 Mn |
| Jun 30, 2024 | 4.51 Mn |
| Mar 31, 2024 | 2.67 Mn |
| Dec 31, 2023 | 3.52 Mn |
| Sep 30, 2023 | 199,839.00 |
| Jun 30, 2023 | 158,832.00 |
| Mar 31, 2023 | 4.67 Mn |
| Dec 31, 2022 | 11.37 Mn |
| Sep 30, 2022 | 12.25 Mn |
| Jun 30, 2022 | 8.73 Mn |
| Mar 31, 2022 | 9.07 Mn |
| Dec 31, 2021 | 9.84 Mn |
| Sep 30, 2021 | 10.26 Mn |
API Access
Silo Pharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SILO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SILO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SILO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();